GLP-1 on Non-ST-Segment Elevation Myocardial Infarction
Status:
Unknown status
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The investigators planned to evaluate the effects of liraglutide on left ventricular function
in patients with non-ST-segment elevation myocardial infarction (NSTEMI).